1. Home
  2. LEGN vs BOKF Comparison

LEGN vs BOKF Comparison

Compare LEGN & BOKF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LEGN
  • BOKF
  • Stock Information
  • Founded
  • LEGN 2014
  • BOKF 1910
  • Country
  • LEGN United States
  • BOKF United States
  • Employees
  • LEGN N/A
  • BOKF N/A
  • Industry
  • LEGN Biotechnology: Pharmaceutical Preparations
  • BOKF Major Banks
  • Sector
  • LEGN Health Care
  • BOKF Finance
  • Exchange
  • LEGN Nasdaq
  • BOKF Nasdaq
  • Market Cap
  • LEGN 5.4B
  • BOKF 6.0B
  • IPO Year
  • LEGN 2020
  • BOKF N/A
  • Fundamental
  • Price
  • LEGN $38.80
  • BOKF $98.57
  • Analyst Decision
  • LEGN Strong Buy
  • BOKF Hold
  • Analyst Count
  • LEGN 11
  • BOKF 10
  • Target Price
  • LEGN $74.60
  • BOKF $112.80
  • AVG Volume (30 Days)
  • LEGN 1.4M
  • BOKF 267.1K
  • Earning Date
  • LEGN 08-11-2025
  • BOKF 07-21-2025
  • Dividend Yield
  • LEGN N/A
  • BOKF 2.31%
  • EPS Growth
  • LEGN N/A
  • BOKF 17.28
  • EPS
  • LEGN N/A
  • BOKF 8.36
  • Revenue
  • LEGN $728,303,000.00
  • BOKF $2,074,957,000.00
  • Revenue This Year
  • LEGN $65.33
  • BOKF $6.03
  • Revenue Next Year
  • LEGN $54.68
  • BOKF $7.38
  • P/E Ratio
  • LEGN N/A
  • BOKF $11.79
  • Revenue Growth
  • LEGN 112.46
  • BOKF 4.66
  • 52 Week Low
  • LEGN $27.34
  • BOKF $85.08
  • 52 Week High
  • LEGN $59.62
  • BOKF $121.58
  • Technical
  • Relative Strength Index (RSI)
  • LEGN 47.38
  • BOKF 40.02
  • Support Level
  • LEGN $38.53
  • BOKF $103.54
  • Resistance Level
  • LEGN $45.30
  • BOKF $107.55
  • Average True Range (ATR)
  • LEGN 1.76
  • BOKF 2.55
  • MACD
  • LEGN -0.61
  • BOKF -0.88
  • Stochastic Oscillator
  • LEGN 9.73
  • BOKF 11.32

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

About BOKF BOK Financial Corporation

BOK Financial Corp is a financial institution in Oklahoma, and it provides a comprehensive range of nationally competitive financial products and services. Its operating segments consist of commercial banking, consumer banking, and wealth management. The company has various products and services, including cash management services, loans and deposits, fiduciary and insurance services, mortgage banking, and brokerage and trading services. It generates maximum revenue from the commercial banking segment. Its commercial banking segment includes lending, treasury and cash management services, and customer risk management products to small businesses, middle market, and larger commercial customers.

Share on Social Networks: